arXiv:2605.10430v2 Announce Type: replace Abstract: Estimating heterogeneous treatment effects with machine learning has attracted substantial attention in both academic research and industrial practice. However, the two communities often evaluate models under markedly different conditions. Methodological work typically relies on semi-simulated benchmarks and metrics that require counterfactual outcomes, whereas real-world applications rely on observable metrics based on ranking or test outcomes. Despite the well-known gap between methodological progress and practical deployment, the relations
The proliferation of machine learning in diverse applications necessitates better evaluation methodologies that bridge academic research and real-world deployment.
Improved evaluation for treatment effect estimation will lead to more reliable and responsible AI applications, particularly in critical decision-making contexts.
The proposed rethinking of evaluation metrics and benchmarks could standardize how AI models are assessed, enhancing trust and accelerating adoption in practical settings.
- · AI ethicists
- · Healthcare providers leveraging AI
- · Policy makers using AI for social interventions
- · Developers of poorly validated AI models
- · Sectors reliant on un-interpretable AI
- · Academic groups resistant to real-world evaluation
More robust and trustworthy AI systems for treatment effect estimation.
Increased adoption of AI in domains where causal inference is critical, such as personalized medicine and adaptive education.
Reduced 'AI washing' and greater scrutiny on the real-world performance of machine learning applications.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG